Skip to content
OpenCapital
Get started

Bunge BG Other Oilseeds Processing and Refining — Goodwill, Gross

Similar metrics at other companies

Innospec logo
IOSPOilfield Services — Goodwill Gross
$46.8M+4.2%
MPLX logo
MPLXCrude Oil and Products Logistics — Gross goodwill
$7.65B0.0%
Delek US Holdings logo
DKRefining — Gross goodwill balance
$801.3M0.0%
Suburban Propane Partners logo
SPHFuel Oil And Refined Fuels — Goodwill Gross
$10.9M0.0%
Innospec logo
IOSPOilfield Services — Goodwill
$46.8M+4.2%
Marathon Petroleum logo
MPCRefining & Marketing — Gross goodwill
$6.14B0.0%

Other financials

Income statement

See full
Revenue$21.9B+87.8%
Gross profit$766.0M+28.3%
Net income$68.0M-66.2%
EPS (diluted)$0.35-76.4%

Balance sheet

See full
Cash & equivalents$847.0M-73.9%
Total debt$19.4B+116%
Total equity$16.0B+51.7%
Total assets$47.6B+78.5%

Cash flow

See full
Operating cash flow-$541.0M-89.8%
CapEx$336.0M+8.4%
Free cash flow-$877.0M-47.4%

Valuation

See full
Market cap$20.71B+86.7%
Enterprise value$39.29B+96.2%
P/E30.3×+22.3×
P/S0.3×0.0×

Profitability

See full
Gross margin4.4%-1.6pp
Net margin0.8%-1.3pp
FCF margin-1.1%-3.3pp

Returns & leverage

See full
Return on equity5.1%-5.2pp
Debt / equity1.2×+0.4×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Bunge in its filing.

Tagged under the XBRL concept us-gaap:GoodwillGross.

The official record: Bunge’s 10-K, filed February 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bunge's other oilseeds processing and refining — goodwill, gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bunge's other oilseeds processing and refining — goodwill, gross?
Bunge (BG) reported other oilseeds processing and refining — goodwill, gross of $153M in Q4 2025.
What does other oilseeds processing and refining — goodwill, gross mean?
The total unadjusted value of goodwill recorded for acquisitions within the oilseeds processing and refining segment. It represents the premium paid over the fair value of net identifiable assets during past business combinations. This figure serves as the baseline for assessing potential future impairment risks.